九安医疗：天开九安海河海棠科创母基金层面直接及间接持有沐曦科技首次公开发行前约0.53%的股份

Core Viewpoint - The company has made significant investments through its mother fund and other funds, totaling up to 35.6 billion RMB, with a direct investment of 1 billion RMB in Muxi Technology, representing a small percentage of its pre-IPO shareholding [1] Investment Details - The company participated in the Tian Kai Jiu An Hai He Hai Tang Science and Technology Innovation Mother Fund with an investment not exceeding 35.6 billion RMB or its equivalent in USD [1] - The mother fund directly invested 1 billion RMB in Muxi Technology, which accounts for 0.47% of its pre-IPO total share capital [1] - The Lisi Xing Muxi Fund holds 1.76% of Muxi's pre-IPO total share capital, with the mother fund indirectly holding approximately 0.53% of Muxi Technology's shares through its investment in the subsidiary fund [1]